Unbound MEDLINE

An iron-based T (1) contrast agent made of iron-phosphate complexes: In vitro and in vivo studies. Magma (New York, N.Y.) [MAGMA] Journal article

 
TitleAn iron-based T (1) contrast agent made of iron-phosphate complexes: In vitro and in vivo studies.
Author(s)Rodríguez E, Simoes RV, Roig A, Molins E, Nedelko N, Slawska-Waniewska A, Aime S, Arús C, Cabañas ME, Sanfeliu C, Cerdán S, García-Martín ML 
InstitutionInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193, Bellaterra, Spain, evrodriguez@partners.org.
SourceMAGMA 2007 Feb; 20(1):27-37.
AbstractA new iron-based T (1) contrast agent consisting of a complex of iron ions coordinated to phosphate and amine ligands (Fe((phos)) in short) has been characterized by spectroscopic and magnetic measurements. NMR relaxation studies showed r (1) values to be dependent on the phosphate salt concentration, K(2)HPO(4), present in the medium. r (1) reaches a maximum value of 2.5 mM(-1) s(-1) for measurements carried out at 7 T and 298 K. (31)P MRS, Mössbauer spectroscopy and magnetic measurements of Fe((phos)) solutions suggest paramagnetic Fe(3+) ions present in the studied iron-phosphate complex. In vitro and in vivo toxicity experiments with C6 cells and CD1 mice, respectively, demonstrated lack of toxicity for Fe((phos)) at the highest dose tested in the MRI experiments (12 mM iron for C6 cells and 0.32 mmol iron/kg for mice). Finally, T (1) weighted images of brain tumours in mice have shown positive contrast enhancement of Fe((phos)) for tumour afflicted regions in the brain.
Languageeng
Pub Type(s)Journal Article
PubMed ID17268782
  
Advertise on this site.